Vera Koppenburg

Oberhaching, BY, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 9 publications

Recommendations for the Development and Validation of Immunogenicity Assays in Support of Biosimilar Programs.

Recommendations for the Development and Validation of Immunogenicity Assays in Support of Biosimilar Programs.

Journal: The AAPS journal

Published: July 11, 2019

Correction to: Recommendations for the Development and Validation of Neutralizing Antibody Assays in Support of Biosimilar Assessment.

Correction to: Recommendations for the Development and Validation of Neutralizing Antibody Assays in Support of Biosimilar Assessment.

Journal: The AAPS journal

Published: March 01, 2018

Recommendations for the Development and Validation of Neutralizing Antibody Assays in Support of Biosimilar Assessment.

Recommendations for the Development and Validation of Neutralizing Antibody Assays in Support of Biosimilar Assessment.

Journal: The AAPS journal

Published: May 23, 2017

Erratum to: Systematic Verification of Bioanalytical Similarity Between a Biosimilar and a Reference Biotherapeutic: Committee Recommendations for the Development and Validation of a Single Ligand-Binding Assay to Support Pharmacokinetic Assessments.

Erratum to: Systematic Verification of Bioanalytical Similarity Between a Biosimilar and a Reference Biotherapeutic: Committee Recommendations for the Development and Validation of a Single Ligand-Binding Assay to Support Pharmacokinetic Assessments.

Journal: The AAPS journal

Published: April 05, 2017

T-cell assays confirm immunogenicity of tungsten-induced erythropoietin aggregates associated with pure red cell aplasia.

T-cell assays confirm immunogenicity of tungsten-induced erythropoietin aggregates associated with pure red cell aplasia.

Journal: Blood advances

Published: October 03, 2016

N-glycan PK Profiling Using a High Sensitivity nanoLCMS Work-Flow with Heavy Stable Isotope Labeled Internal Standard and Application to a Preclinical Study of an IgG1 Biopharmaceutical.

N-glycan PK Profiling Using a High Sensitivity nanoLCMS Work-Flow with Heavy Stable Isotope Labeled Internal Standard and Application to a Preclinical Study of an IgG1 Biopharmaceutical.

Journal: Pharmaceutical research

Published: December 10, 2014

A fit-for-purpose strategy for the risk-based immunogenicity testing of biotherapeutics: a European industry perspective.

A fit-for-purpose strategy for the risk-based immunogenicity testing of biotherapeutics: a European industry perspective.

Journal: Journal of immunological methods

Published: July 01, 2014

Systematic verification of bioanalytical similarity between a biosimilar and a reference biotherapeutic: committee recommendations for the development and validation of a single ligand-binding assay to support pharmacokinetic assessments.

Systematic verification of bioanalytical similarity between a biosimilar and a reference biotherapeutic: committee recommendations for the development and validation of a single ligand-binding assay to support pharmacokinetic assessments.

Journal: The AAPS journal

Published: April 21, 2014

Target-directed development and preclinical characterization of the proposed biosimilar rituximab GP2013.

Target-directed development and preclinical characterization of the proposed biosimilar rituximab GP2013.

Journal: Leukemia & lymphoma

Published: September 13, 2013

Showing 1-9 of 9

Last Updated: 09/26/2026